Joseph D. Buxbaum
5Patents
3h-index
8Co-inventors
46Inventor score
Filing activity: Jun 7, 1993 → Mar 21, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5385915A | Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation | Human Necessities | 100 | Expired |
| US5538983A | Method of treating amyloidosis by modulation of calcium | Human Necessities | 35 | Expired |
| US5928882A | Treatment and prevention of neurodegenerative diseases using modulators of Fe65 | Human Necessities | 5 | Expired |
| US8691762B2 | Methods and assays for treating subjects with SHANK3 deletion, mutation or reduced expression | Physics | 3 | Active |
| US9243293B2 | Genes associated with posttraumatic-stress disorder (PTSD) | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.